{
  "id": "64403ab057b1c7a31500004d",
  "type": "factoid",
  "question": "How many injections of CLS-TA did the patients participating in the PEACHTREE trial receive?",
  "ideal_answer": "The patients participating in the PEACHTREE trial received two suprachoroidal injections of CLS-TA at 0 and 12 weeks.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/34322164"
  ],
  "snippets": [
    {
      "text": "Recent results from the PEACHTREE trial (ClinicalTrials.gov Identifier: NCT02595398), a phase III trial with two suprachoroidal injections of CLS-TA at 0 and 12 weeks with follow up lasting 24 weeks, showed the significant improvement in visual acuity and reduction in central subfield thickness, all without increasing the risk of elevated intraocular pressure or accelerated cataract progression.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34322164",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "two, 2"
}